AB-1975 Medi-Cal: medically supportive food and nutrition interventions.
This bill would make medically supportive food and nutrition services a permanent covered benefit for all eligible beneficiaries under the Medi-Cal program.
SB 1099 Newborn screening: genetic diseases: blood samples collected. (Nguyen)
PROBLEM: The genetic material of mothers and children is being stored in the California Biobank and used for research for public health purposes, but there is no transparency into what research is being conducted, what entities are utilizing the residual blood samples, or what specific public health benefits have been achieved.
SOLUTION: This bill would ensure that the public has access to information about the activities of the California Biobank by requiring CDPH to annually prepare a report, deliver a copy of the report to the Legislature, and post the report on their website. The report would be required to contain information such as:
AB-1975 Medi-Cal: medically supportive food and nutrition interventions.
This bill would make medically supportive food and nutrition services a permanent covered benefit for all eligible beneficiaries under the Medi-Cal program.
AB-1977 Health care coverage: behavioral diagnoses
This bill would prohibit a health care service plan contract or health insurance policy from requiring an enrollee or insured previously diagnosed with pervasive developmental disorder (PDD) or autism to be re-evaluated or receive a new behavioral diagnosis to maintain
coverage for behavioral health treatment for theircondition.
AB-2051 Psychology interjurisdictional compact
AB 2051 would ratify, and approve the Psychology Interjurisdictional Compact (PSYPACT), an interstate compact that allows for the practice of telepsychology
and temporary in-person psychology across state lines.
AB-2066 The California Food Safety Act
This bill would prohibit a person or entity from using Methylene Chloride in the process of decaffeinating coffee. It would protect coffee consumers and make decaffeinated coffee safer.
AB 2300 Medical devices: Di-(2-ethylhexyl) phthalate (DEHP).
This bill would ban the manufacture, sale and use of Di(2-ethylhexyl)phthalate (DEHP) in IV bags and tubing in California. DEHP has been linked to breast, liver, lung, and testicular cancer; it is an endocrine disrupting compound linked to early puberty, decreased sperm count and infertility.
This bill would require a local educational agency to ensure that the parent understands the proceedings during the planning process for the individualized education program, including communicating in the parent’s native language, or in another mode of communication used by the parent, arranging for an interpreter, providing translation services, and providing alternative communication services.
AB-2761 Product safety: plastic packaging: Reducing Toxics in Packaging Act.
This bill would ban the sale of toxic plastic packaging containing PFAS or made of PVC /PVDC. These toxic materials are among the “worst-of-the-worst" forms of plastic, and eliminating them will protect public health and the environment, and support the creation of a more circular economy.
SB 1250 Privacy: genetic testing: newborn screening.
This bill would apply the requirements of the Genetic Information Privacy Act regarding consent for collection, use, or disclosure of the consumer’s genetic data to the California Newborn Screening Program beginning on January 1, 2025.
SB-1266 Product safety: perfluoroalkyl and polyfluoroalkyl substances.
AB-2105 Coverage for PANDAS and PANS.
This bill would require a health care service plan contract or health insurance policy to provide coverage for the prophylaxis, diagnosis, and treatment of Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS) and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) that is prescribed or ordered by the treating physician and surgeon. The bill would prohibit coverage for PANDAS and PANS from being subject to a copayment, coinsurance, deductible, or other cost sharing that is greater than that applied to other benefits.
SB 903 Environmental health: product safety: perfluoroalkyl and polyfluoroalkyl substances.
This bill would prohibit a person from distributing, selling, or offering for sale a product that contains intentionally added PFAS, as defined, unless the Department of Toxic Substances Control has made a determination that the use of PFAS in the product is a currently unavoidable use, the prohibition is preempted by federal law, or the product is used.